Sign in

Philip Bejon

@philipbejon.bsky.social
178 followers 169 following 182 posts

Director @modmedmicro.bsky.social; Previous Director @kemri_wellcome; Researcher on vaccines, malaria, viruses; Clinical Microbiologist, Infectious Disease, General Medicine

PostsRepliesMedia
Reposted by Philip Bejon
Bash the bug @bashthebug.net · 29/09/2026
Infusoria BioArt exhibition exploring microbiology opens at the John Radcliffe Hospital! 📅 26 September – 6 November 2026 📍 Artlink Corridor Gallery, John Radcliffe Hospital, Oxford #ArtAndScience #Microbiology #AntimicrobialResistance #InfectionPrevention #PublicEngagement
bashthebug.net
Infusoria BioArt exhibition exploring microbiology opens at the John Radcliffe Hospital
BioArt exhibition exploring microbiology opens at the John Radcliffe Hospital A new display of work by artist Anna Dumitriu is now on show at the John Radcliffe Hospital, bringing together art, microbiology and research into healthcare-associated infections. The exhibition draws on research from Modernising Medical Microbiology into hospital environments, bacteria and antimicrobial resistance. Through BioArt, Anna’s work explores the microbial world that usually remains unseen and encourages people to think differently about the relationship between microorganisms, healthcare and our surroundings.
043
Reposted by Philip Bejon
Sam Lipworth @samlipworth.bsky.social · 7h
Great new work from @dotnagy.bsky.social who has developed EpiSENTRY which performs sample size calculations for public health WGS surviellance studies. She applies to data from the NEKSUS study to estimate how much sequencing is enough for GNBSI surviellance in England. @modmedmicro.bsky.social
medrxiv.org
How much is enough? Optimising sampling frames for genomic surveillance of Escherichia coli and Klebsiella spp. bloodstream infections - a retrospective study
Background: Optimising sampling frames for genomic surveillance of E. coli and Klebsiella may support interventions to mitigate bloodstream infections (BSIs), but approaches to estimating sample size ...
087
Reposted by Philip Bejon
NEJM.org @nejm.org · 16/09/2026
In a randomized trial involving adults who received local antibiotics during surgery for orthopedic infection, a short duration of systemic antibiotics was noninferior to a long duration regarding treatment failure at 12 months. Full SOLARIO trial results: nej.md/4dgrqwY
This image shows a forest plot showing the robustness of the primary analysis results. Subgroups include definite treatment failure, definite or probable treatment failure, and definite, probable, or possible treatment failure. Hazard ratios with 95% confidence intervals are displayed, indicating whether a short duration is better than a long duration. A red line indicates the noninferiority margin.
074
Reposted by Philip Bejon
Ilan Schwartz @germhuntermd.bsky.social · 17/09/2026
Less is more, ortho-ID edition Another game changer in ortho ID from the group that brought you OVIVA Pts with ortho infections who underwent curative surgery (no DAIR) with local implantation of abx were randomized to <=7d vs >=4w ABx No Dif in 12 mo relapse www.nejm.org/doi/full/10.... #IDSky
Forest plot with primary analysis results which shows no difference in definite treatment failure, definite/probable treatment failure, or definite/probable/possible treatment failure according to treatment durationForest plot showing subgroup analysis which shows no difference between shorter and longer duration antibiotics in any of the subgroups including prosthetic infection, Staph aureus mono infection, and whether local gentamicin was used in mono therapy or combination therapy
23217
Reposted by Philip Bejon
Michael Marks @drmichaelmarks.bsky.social · 14/09/2026
Cutaneous leishmaniasis is a major problem in Ethiopia & often requires admission for systemic therapy. Liquid nitrogen cryotherapy is an option but also has significant logistic barriers. We evaluated leveraging CO2 cryotherapy deployed for cervical cancer to decenteralise treatment for CL.
journals.plos.org
Diagnosis of localized cutaneous leishmaniasis and treatment outcomes following carbon dioxide cryotherapy performed by health centre staff: A pilot implementation study in Ethiopia
Author summary Cutaneous leishmaniasis (CL) is a neglected tropical disease (NTD) of the skin caused by species of the genus Leishmania. It is endemic in Ethiopia’s highland regions. Affected individu...
121
Philip Bejon @philipbejon.bsky.social · 14/09/2026
Vapes can bring their own problems, but hard to deny the importance of quitting tobacco, the difficulty of quitting, and that they seem to help.
000
Philip Bejon @philipbejon.bsky.social · 11/09/2026
New publication from @modmedmicro.bsky.social on metagnomic RNA virus detection from upper respiratory samples - www.sciencedirect.com/science/arti... @nickdsandy.bsky.social @treestreet.bsky.social @dotnagy.bsky.social @samlipworth.bsky.social @oxfordbrc.bsky.social
sciencedirect.com
Clinical validation of an optimised metagenomic nanopore sequencing method for detecting viral respiratory pathogens
Clinical metagenomics (CMg) offers high-throughput respiratory pathogen detection with a wider range than targeted, probe-dependent diagnostics. Seque…
126
Reposted by Philip Bejon
Bash the bug @bashthebug.net · 03/09/2026
Microbiology is coming out of the lab! Infusoria, a new exhibition by MMM Artist-in-Residence Anna Dumitriu, runs in the JR Hospital from 26 Sept–6 Nov 2026. New works inspired by Oxford research explore hospital sinks, wastewater, water microbiomes and antimicrobial resistance.
bashthebug.net
When microbiology becomes art: Infusoria
Infusoria 26 September – 6 November 2026Artlink Corridor Gallery, John Radcliffe Hospital, Oxford From hospital sinks to BioArt: our microbiology research inspires new exhibition Infusoria What does the microbial world of a hospital sink look like when viewed not only through the lens of microbiology, but through art? Research from Modernising Medical Microbiology (MMM) at the University of Oxford&hellip;
045
Reposted by Philip Bejon
KEMRI-Wellcome @kemriwellcome.bsky.social · 02/09/2026
Congratulations to our Executive Director, Prof. Edwine Barasa, on his appointment to the renewed @who.int Science Council, joining 20 leading scientists globally. The Council will advise on emerging technologies,breakthroughs & high-priority health issues shaping global health. 🔗: shorturl.at/hQybK
044
Reposted by Philip Bejon
edwinebarasa.bsky.social @edwinebarasa.bsky.social · 01/09/2026
Honoured to be appointed to the WHO Science Council, joining 20 leading scientists from around the world to help shape the future of science, research and innovation for global health. Excited about the work ahead. @kemriwellcome.bsky.social www.who.int/news/item/27...
who.int
WHO appoints 21 leading scientists to Science Council to help shape future health breakthroughs
The WHO Science Council is an advisory body established by the WHO Director-General to provide independent advice on high-priority scientific issues, emerging technologies, and advances in science and...
024
Reposted by Philip Bejon
BK. Titanji @boghuma.bsky.social · 27/08/2026
An outbreak of Mpox is unfolding in Guinea Bissau. Madagascar is also experiencing its first ever outbreak. I would argue that Mpox never left. We have not made the necessary investments in global surveillance and targeted immunization. www.theguardian.com/global-devel...
theguardian.com
Mpox is back – and in new countries. How can this outbreak be contained?
The public health emergencies in 2022 and 2024 saw the virus reported in 145 countries, but in the new cases children appear particularly affected
38853
Reposted by Philip Bejon
BK. Titanji @boghuma.bsky.social · 21/08/2026
Our new review is out! We examine the JAK/STAT pathway as a therapeutic target in chronic viral infections, including HIV, hepatitis viruses, SARS-CoV-2 & herpesviruses and the balance between reducing harmful inflammation while preserving antiviral immunity. www.frontiersin.org/journals/imm...
frontiersin.org
Frontiers | Targeting the JAK/STAT pathway in chronic viral infections: opportunities and challenges for immunomodulation
The discovery of the Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway as a key regulator of immune function and inflammation ...
14412
Reposted by Philip Bejon
Oxford Medical Sciences Division @medsci.ox.ac.uk · 19/08/2026
NEWS: 100th patient enrolled in PARTNERS trial to identify the first effective treatments for Bundibugyo ebolavirus disease @psioxford.bsky.social 
medsci.ox.ac.uk
100th patient enrolled in PARTNERS trial to identify the first effective treatments for Bundibugyo ebolavirus disease
This milestone, reached just 12 weeks after the announcement of the outbreak, makes PARTNERS the fastest-ever randomised controlled trial of treatments for Ebola.
042
Reposted by Philip Bejon
RTarlinton.bsky.social @rtarlinton.bsky.social · 18/08/2026
This sort of work is what public health should be , patient, collaborative, consistent , over a long enough period of time to really see what’s happening ( and a fantastic drop in childhood deaths to boot)
023
Reposted by Philip Bejon
Katja @jaggakatja.bsky.social · 18/08/2026
Great news!! This drop in hospitalisations and deaths in children due to malaria really need to be more widely appreciated!
021
Reposted by Philip Bejon
BK. Titanji @boghuma.bsky.social · 18/08/2026
This is truly great work. Thanks for sharing and congratulations to the team.
042
Reposted by Philip Bejon
Hannah Slater @hannahslater.bsky.social · 18/08/2026
Great article and an important message - there's a lot of emphasis on the next hot new malaria intervention, but always important to remember that the fundamentals done really well can have a huge and sustained impact.
041
Philip Bejon @philipbejon.bsky.social · 18/08/2026
Kilifi is a coastal County in Kenya, where @kemriwellcome.bsky.social has undertaken 35 years sentinel surveillance of malaria. Dramatic changes that I think aren't widely appreciated. Work led by @alice-kamau.bsky.social Highlights and link to paper:
2146
Reposted by Philip Bejon
Global Health EDCTP3 @globalhealthedctp3.bsky.social · 30/06/2026
Investing in people, creating lasting impact #EDCTP-supported researcher Prof. Abdoulaye Djimdé has been featured in Nature for his contribution to advancing the fight against malaria and strengthening African-led research capacity. 🔗 Read the article: www.nature.com/articles/d44...
062
Reposted by Philip Bejon
KEMRI-Wellcome @kemriwellcome.bsky.social · 29/06/2026
🎓Fully funded PhD opportunity! 🔬Ready to make an impact in child health research? Apply for the PhD studentship under the RECOVER study and help improve care for children with severe acute malnutrition. 🔗Apply here👉: shorturl.at/RqNiS 🗓️Deadline : July 3, 2026
013
Reposted by Philip Bejon
Michael Marks @drmichaelmarks.bsky.social · 17/06/2026
Come work @lshtm.bsky.social modelling STIs in UK & evaluation of new interventions. 3yr research fellow modelling post - feel free to get in touch to discuss. Current closing date 30th June @rozeggo.bsky.social @adamjkucharski.bsky.social @grahammedley.bsky.social @drlouisedyson.bsky.social
jobs.lshtm.ac.uk
Job Opportunity at LSHTM: Research Fellow
The London School of Hygiene & Tropical Medicine (LSHTM) is one of the world’s leading public health universities. Our mission is to improve health and health equity in the UK and worldwide; working i...
0814
Reposted by Philip Bejon
Ursula Hofer @hoferu.bsky.social · 10/06/2026
"[...] as of May 27, 2026, approximately 280–2520 cases of Bundibugyo virus disease might have occurred in [DRC] (estimate range 306–2521 with the back-calculation model and 282–1345 with the geographical spread model); however, there is considerable uncertainty around these estimates."
121
Reposted by Philip Bejon
Ursula Hofer @hoferu.bsky.social · 10/06/2026
Updated modelling of the current size of the Ebola outbreak by Imperial and collaborators. Ruth McCabe and co-authors did an incredible job at integrating continuously changing case data 👇
thelancet.com
Estimation of the Ebola outbreak size in the Democratic Republic of the Congo
The ongoing outbreak of Bundibugyo virus disease, a form of Ebola virus disease caused by the Bundibugyo virus, in the Democratic Republic of the Congo is evolving rapidly. As of May 27, 2026, 1031 su...
233
Reposted by Philip Bejon
KEMRI-Wellcome @kemriwellcome.bsky.social · 09/06/2026
🚨Vaccinology webinar alert!🚨 🧪Curious about how vaccines are developed and standardized? Join our next webinar session with Dr. Selorm Avumegah, @cepi.net, and learn how standards ensure the quality, safety, and effectiveness of vaccines. 🗓️June 24th, 2026 🕑2:00 PM – 3:30 PM EAT 🔗: shorturl.at/4zUWK
013
Reposted by Philip Bejon
KEMRI-Wellcome @kemriwellcome.bsky.social · 09/06/2026
🫀How can Africa tackle the growing burden of hypertension? 📚Our latest research highlights why combining proven interventions with locally generated evidence is key to developing solutions that work for African populations. 🔗Read more here 👉: shorturl.at/7FAf4
013
Reposted by Philip Bejon
Bash the bug @bashthebug.net · 01/06/2026
NIHR webinar on BashTheBug on YouTube BashTheBug was originally a large international citizen science project that invited anyone to help us classify how well different samples of M. tuberculosis grew in the presence of a range of antibiotics. It ran from 2017 to 2021 and in that time 46,427…
bashthebug.net
NIHR webinar on BashTheBug on YouTube
BashTheBug was originally a large international citizen science project that invited anyone to help us classify how well different samples of M. tuberculosis grew in the presence of a range of antibiotics. It ran from 2017 to 2021 and in that time 46,427 people took part and collectively they classified 4,746,420 images of M. tuberculosis growing on different concentrations of one of 13 antibiotics. 
022
Reposted by Philip Bejon
University of Oxford @ox.ac.uk · 01/06/2026
NEW: An Oxford-developed vaccine candidate targeting the Bundibugyo strain of Ebola has received backing from CEPI, accelerating efforts to respond to the epidemic in the Democratic Republic of the Congo and Uganda. More info ➡️ bit.ly/4uif4KI
Illustration of an Ebola virus particle with a headline about CEPI backing for an Oxford Bundibugyo ebolavirus vaccine candidate.
0149
Reposted by Philip Bejon
Bash the bug @bashthebug.net · 28/05/2026
Thanks to the team for all their hardwork preparing and delivering the activities, especially in this heatwave! 🌞🌞🌞
033
Reposted by Philip Bejon
Bash the bug @bashthebug.net · 28/05/2026
And our DNA detective programme was a smash🕵‍♀️ Follow the bioinformatic instructions to figure out which patient in a ward has which infection, and work out from the hints which drugs will help the patient get better!
122
Reposted by Philip Bejon
Bash the bug @bashthebug.net · 28/05/2026
The Mystery Outbreak poster was a hit! A cluedo-esque mystery where you had to follow the clues to find the source of illness in the hospital 🔍
132
Reposted by Philip Bejon
Bash the bug @bashthebug.net · 28/05/2026
Everybody loved the strawberry DNA extractions!🍓 Participants learnt how this technique can be used by scientists to diagnose infections in patients and the data used by doctors to see if the infection has any resistance and then choose which antibiotics to prescribe🧬 @oxfordbrc.bsky.social
143
Reposted by Philip Bejon
Bash the bug @bashthebug.net · 28/05/2026
We had an amazing time in Westgate, Oxford today! We had many attempts to 'bash the bug' and get the high score for the day on our dance mat 💃🕺 where overusing antibiotics causes resistance so you have to be careful what you're prescribing!💊 #AMR #ScienceOutreach #Microbiology #Oxford
184
Reposted by Philip Bejon
Katharine Collins @kat-a-collins.bsky.social · 26/05/2026
Today, Coefficient Giving is launching the Strep A Vaccine Fund, a multi-donor initiative to accelerate vaccine development against one of the world's most neglected infectious diseases relative to its scale. Strep A kills ~639,000 people a year. There is no vaccine. I think that can change 🧵
12212
Reposted by Philip Bejon
Oxford Medical Sciences Division @medsci.ox.ac.uk · 07/05/2026
NEWS: New rabies vaccine could provide protection for adults and children with a single dose The vaccine could provide an affordable way to protect vulnerable populations.
medsci.ox.ac.uk
New rabies vaccine could provide protection for adults and children with a single dose
A new clinical trial led by researchers at the Jenner Institute in collaboration Ifakara Health Institute Tanzania, suggests that a single-dose rabies vaccine could provide safe, long-lasting protection in both adults and children. The research could lead to a simpler, lower-cost approach that could transform rabies prevention in high-risk regions.
071
Reposted by Philip Bejon
KEMRI-Wellcome @kemriwellcome.bsky.social · 07/05/2026
Congratulations to Prof. Isabella Oyier and Prof. Ambrose Agweyu on their appointments as Deputy Director, Kilifi and Nairobi, respectively, following the completion of a competitive recruitment process. Read more below 🔗Isabella's profile: shorturl.at/TFiMP 🔗Ambrose's profile: shorturl.at/MHtO1
044
Reposted by Philip Bejon
KEMRI-Wellcome @kemriwellcome.bsky.social · 05/05/2026
Congratulations to Prof. Charles Agoti on being awarded the title of Associate Professor at @ox.ac.uk in recognition of his research achievements and contribution to academic excellence in the @ndm.ox.ac.uk!
013
Reposted by Philip Bejon
KEMRI-Wellcome @kemriwellcome.bsky.social · 29/04/2026
🎓Congratulations to Dr. Fatuma Guleid on successfully defending her PhD thesis! Her research explores how knowledge translation can be reframed to strengthen evidence-informed health policy making in Kenya. Fatuma was supervised by Prof. Edwine Barasa, Dr. Jacinta Nzinga & Prof. Gilbert A. Abiiro.
013
Philip Bejon @philipbejon.bsky.social · 27/04/2026
Great intervention - makes everything better, malaria, respiratory infection, diarrhoea, growth - and low carbon footprint. Nothing not to like.
112
Reposted by Philip Bejon
Adam Kucharski @adamjkucharski.bsky.social · 24/04/2026
Claude has started refusing to give citations. Yes, this technically means fewer hallucinations. But it doesn’t mean that AI is now hallucination-free in the way a careful researcher is.
73010
Reposted by Philip Bejon
KEMRI-Wellcome @kemriwellcome.bsky.social · 24/04/2026
For decades, the Programme has led malaria research, generating evidence, shaping policy, and driving progress. This upcoming #WorldMalariaDay, we reflect on impact, progress, and priorities ahead to move closer to a malaria-free future. As captured by leading malaria researcher Prof. Bob Snow:
045
Reposted by Philip Bejon
Onisillos @onisillos.bsky.social · 24/04/2026
"We find that current LLMs are unreliable delegates: even frontier models corrupt an average of 25% of document content over long workflows, with sparse but severe errors that silently compound over time." 👉"Silently" arxiv.org/abs/2604.15597
arxiv.org
LLMs Corrupt Your Documents When You Delegate
Large Language Models (LLMs) are poised to disrupt knowledge work, with the emergence of delegated work as a new interaction paradigm (e.g., vibe coding). Delegation requires trust - the expectation t...
085
Reposted by Philip Bejon
KEMRI-Wellcome @kemriwellcome.bsky.social · 23/04/2026
🚨Vaccinology webinar alert!🚨 How can we empower local manufacturing through vaccine technology transfer ? Register for the upcoming Vaccinology career webinar to learn more! 🗓️ April 30th, 2026 🕑 2:00 PM – 3:30 PM EAT 🔗Register here👉: shorturl.at/q7Vvz
013
Reposted by Philip Bejon
Michael Marks @drmichaelmarks.bsky.social · 08/04/2026
Clinical PhD opportunity @lshtm.bsky.social through @hpruezi.bsky.social Applications now close on 17th April. Ideal for UK Infection registrars wanting to do a PhD in clinical application of metagenomics in returning travellers. Collaboration with @emcat1.bsky.social & @ukhsa.bsky.social
jobs.lshtm.ac.uk
Job Opportunity at LSHTM: Clinical Research Fellow
The London School of Hygiene & Tropical Medicine (LSHTM) is one of the world’s leading public health universities. Our mission is to improve health and health equity in the UK and worldwide; working in partnership to achieve excellence in...
077
Reposted by Philip Bejon
Richard Sever @richardsever.bsky.social · 05/04/2026
journals.plos.org/plosbiology/...
journals.plos.org
Biomedical publishing: Past historic, present continuous, future conditional
Academic journals have been publishing the results of biomedical research for more than 350 years. Reviewing their history reveals that the ways in which journals vet submissions have changed over tim...
162
Reposted by Philip Bejon
Modernising Medical Microbiology @modmedmicro.bsky.social · 24/03/2026
On #WorldTBDay, it’s important to reflect on the scale of the challenge we’re facing. In 2024 alone, tuberculosis (TB) caused 1.23 million deaths worldwide, remaining the leading cause of death from a single infectious agent, according to WHO @ndm.ox.ac.uk
144
Reposted by Philip Bejon
Insta Science @instascience.bsky.social · 22/03/2026
This rarely-seen Glass Octopus was caught by an underwater robot during an expedition off the Phoenix Islands.
753117677
Reposted by Philip Bejon
Laura Helmuth @laurahelmuth.bsky.social · 22/03/2026
This is a great list of techniques for getting real information out of a Google search and avoiding AI slop and paid results. (One thing not included is that if you add "-ai" to a search, you block the AI summary) cardcatalogforlife.substack.com/p/google-has...
cardcatalogforlife.substack.com
Google Has a Secret Reference Desk. Here's How to Use It.
40 Google features to find exactly what you need, the alternative search engines that do things Google won't, and the reference desk framework underneath all of it.
5621551011
Reposted by Philip Bejon
Bash the bug @bashthebug.net · 16/03/2026
It was fantastic to see so many people getting involved, asking great questions, and learning about microbiology in the sunshine. Thanks to everyone who came to say hello, and to our brilliant team for all their enthusiasm! #BashTheBug #Microbiology #PublicOutreach #ATOMFestival
034
Reposted by Philip Bejon
Bash the bug @bashthebug.net · 16/03/2026
We had a brilliant time this weekend at ATOM Festival in Abingdon! ☀️🦠 We brought along our favourite interactive activities to help people learn about antimicrobial resistance #AMR, including our dance mat game where you fight germs with antibiotics, and we tested everyone’s handwashing skills!
253
Reposted by Philip Bejon
KEMRI-Wellcome @kemriwellcome.bsky.social · 16/03/2026
🧠Cerebral malaria causes coma and high mortality in children, but diagnosis isn’t always straightforward. New research shows candidate biomarkers, ANGPTL4 and INHBE combined with platelet counts, can help differentiate cerebral malaria from other causes of coma. 📚Read more here👉 : shorturl.at/Ry33l
014